CME and Disclosure

Accreditation and Designation Information
ACCREDITATION STATEMENT

The University of California, Irvine School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

DESIGNATION STATEMENT

The University of California, Irvine School of Medicine designates this live activity for a maximum of 5.25 AMA PRA Category 1 Credits™. Participants should claim only the credit commensurate with the extent of their participation in the activity.

A non-physician Healthcare Professional certificate of attendance for CEU purposes will be provided. Non-physicians may submit the HP certificate to their own credentialing board (nursing, pharmacy, social work, etc.) to see if they can obtain transferrable CEU’s.
Declaration / Disclosure Information
GENERAL DISCLOSURE STATEMENT

It is the policy of the University of California, Irvine School of Medicine to ensure balance, independence, objectivity, and scientific rigor in all educational activities. The views and opinions expressed in this activity are those of the speakers and do not necessarily reflect the views of the University of California, Irvine School of Medicine. Full disclosure will be included during the conference presentation and the UCI School of Medicine CME website.

University of California, Irvine School of Medicine Continuing Medical Education adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers, or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

ADA STATEMENT

In compliance with the Americans with Disabilities Act, we will make every reasonable effort to accommodate your needs. For any special requests, please call (714) 456-6871.

CALIFORNIA ASSEMBLY BILL 1195 AND 241

This activity is in compliance with California Assembly Bill 1195 and 241, which require CME activities with patient care components to include curriculum in the subjects of cultural and linguistic competency & implicit bias. It is the intent of AB 1195 and AB 241 to encourage physicians and surgeons, CME providers in the State of California, and the Accreditation Council for Continuing Medical Education to meet the cultural and linguistic concerns of a diverse patient population and reduce health disparities through appropriate professional development. Please see the CME website, www.meded.uci.edu/cme, for AB 1195 and AB 241 resources.

ACKNOWLEDGEMENT OF COMMERCIAL SUPPORT

The University of California, Irvine School of Medicine thanks the following companies for providing a grant to financially support this educational activity.

Gilead Sciences

ViiV Healthcare

ACKNOWLEDGEMENT OF EXHIBITORS

The University of California, Irvine School of Medicine thanks the following companies for exhibiting at this conference.

Gilead Sciences – Prevention

Gilead Sciences – Treatment

Merck & Co.

Shionogi

ViiV Healthcare – Prevention

ViiV Healthcare – Treatment

Speaker Disclosure

UCI OCME requires that the content of CME activities and related materials provide balance, independence, objectivity, and scientific rigor. Planning must be free of the influence or control of an ineligible company, and promote improvements or quality in healthcare. It is the policy of the UCI Office of Continuing Medical Education to ensure balance, independence, objectivity, and scientific rigor in all its educational activities. All faculty and planners participating in UCI accredited CME programs are required to disclose to the activity participants any real or apparent conflict(s) of interest. This pertains to relationships with pharmaceutical companies, biomedical device manufacturers, or other corporations that may be considered ineligible companies. The intent of this policy is to identify potential conflicts of interest so participants can form their own judgments with full disclosure of the facts. It remains for the participants to determine whether the speaker’s outside interests reflect a possible bias in either the exposition or the conclusions presented.

The following planner and speaker have disclosed the following relationship with an ineligible company:

Speaker Name	Role in Activity	Name of Ineligible Company	Nature of Relevant Relationship	Conflict Resolution Method
Eric Daar, MD	Speaker	Gilead Sciences Merck ViiV Healthcare	Consultant, Grants/Research Support	This presentation has been reviewed by the conference Clinical Director, who reports the stated disclosures have had no affect on the content of this presentation.
Tulika Singh, MD, MHA	Speaker	ViiV Healthcare	Advisor	This presentation has been reviewed by the conference Clinical Director, who reports the stated disclosures have had no affect on the content of this presentation.

The following speakers and planners have indicated they have no relevant financial relationships to disclose:

Ricky Bluthenthal, PhD; Geeta Gupta, MD; Usme Khusbu; Ina Park, MD, MS; Christopher Ried, MD; Suman Srinivasa, MD, MS.